-
Product Insights
Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2017" provides an overview of Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Angiosarcoma Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Angiosarcoma Global Clinical Trials Review, H1, 2017" provides an overview of Angiosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Angiosarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Basal Cell Carcinoma (Basal Cell Epithelioma) Global Clinical Trials Review, H1, 2017" provides an overview of Basal Cell Carcinoma (Basal Cell Epithelioma) clinical trials scenario. This report provides top line data relating to the clinical trials on Basal Cell Carcinoma (Basal Cell Epithelioma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase,...
-
Product Insights
B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2017" provides an overview of B-Cell Chronic Lymphocytic Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on B-Cell Chronic Lymphocytic Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
B-Cell Leukemia Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “B-Cell Leukemia Global Clinical Trials Review, H1, 2017" provides an overview of B-Cell Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on B-Cell Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2017" provides an overview of B-Cell Non-Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on B-Cell Non-Hodgkin Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2017" provides an overview of Bile Duct Cancer (Cholangiocarcinoma) clinical trials scenario. This report provides top line data relating to the clinical trials on Bile Duct Cancer (Cholangiocarcinoma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Bone Cancer Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Bone Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Bone Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Bone Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
EpiCast Report: Chronic Lymphocytic Leukemia – Epidemiology Forecast to 2025
Chronic lymphocytic leukemia (CLL), also known as chronic lymphoid leukemia, is a type of cancer of the white blood cells (lymphocytes). CLL affects a particular lymphocyte, the B cell, which accumulates mainly in the bone marrow and blood, and normally fights infection. CLL is closely related to small lymphocytic lymphoma (SLL), a type of non-Hodgkin's lymphoma that presents primarily in the lymph nodes GlobalData epidemiologists utilized national databases and robust peer-reviewed journal articles to build the CLL diagnosed incident and...
-
Sector Analysis
EpiCast Report: Prostate Cancer – Epidemiology Forecast to 2026
Prostate cancer is a malignancy in the prostate gland, which is located below the bladder and in front of the rectum in males. Worldwide, about 1.1 million men were diagnosed with prostate cancer in 2012. Diagnosed incident cases of prostate cancer is defined as malignant neoplasms with the prostate gland as the primary site (ICD-10 code C61, ICD-O-3 code C61.9). The forecast relies on data from national cancer registries, peer-reviewed journal articles, and primary market research. CRPC was defined as...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.